Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -7,890 | -2,160 | N/A |
| Depreciation Amortization | 144 | 148 | N/A |
| Accounts receivable | -94 | 202 | N/A |
| Other Working Capital | 282 | -649 | N/A |
| Other Operating Activity | 5,345 | 1,291 | 0 |
| Operating Cash Flow | $-2,213 | $-1,168 | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -266 | -5 | N/A |
| Other Investing Activity | -8 | 11 | 0 |
| Investing Cash Flow | $-274 | $6 | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 795 | 12,566 | N/A |
| Common Stock Issued | 6,644 | -500 | N/A |
| Other Financing Activity | -42 | -10,807 | 0 |
| Financing Cash Flow | $7,397 | $1,259 | $N/A |
| Beginning Cash Position | 209 | 112 | N/A |
| End Cash Position | 5,119 | 209 | N/A |
| Net Cash Flow | $4,910 | $97 | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -2,213 | -1,168 | N/A |
| Capital Expenditure | -266 | -5 | N/A |
| Free Cash Flow | -2,479 | -1,173 | 0 |